Encouraging Rigorous Patient-Generated Data All Along the Drug Development Continuum
J Natl Cancer Inst
.
2022 Oct 6;114(10):1313-1314.
doi: 10.1093/jnci/djac129.
Authors
Vishal Bhatnagar
1
,
Paul G Kluetz
1
Affiliation
1
Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
PMID:
35900168
PMCID:
PMC9552273
DOI:
10.1093/jnci/djac129
No abstract available
Publication types
Editorial
Comment
MeSH terms
Continuity of Patient Care*
Drug Development
Humans
Neoplasms* / drug therapy